Skip to content

Geriatric and Oncologic Assessment Before Treatment

Significance of Geriatric Assessment for Optimal Treatment of Older Cancer Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02671994
Acronym
GOAT
Enrollment
114
Registered
2016-02-02
Start date
2016-01-31
Completion date
2019-12-31
Last updated
2019-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Geriatric Assessment, G8 screening, Oncologic treatment

Brief summary

In a randomized controlled trial, the investigators wish to investigate, if oncologic treatment decision based on G8 screening followed by geriatric assessment and subsequent MDT, if needed, in older frail patients with gynaecologic and urologic cancer is superior to standard assessment (PS and clinical assessment) in oncologic treatment decision.

Interventions

OTHERG8 screening
OTHERGeriatric assessment

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Histologically verified gynaecologic cancer (ovarian, uterine, or cervical cancer) or urologic cancer (prostate, bladder, or kidney cancer). * Suited for first line medical oncologic treatment with chemotherapy and/or targeted therapy. * Age ≥ 70 years. * Understands, speaks, and writes Danish. * Signed informed consent.

Exclusion criteria

* Previous cancer diagnosis except for carcinoma in situ of the cervix or skin cancer other than malignant melanoma. * Previous chemotherapy and/or targeted therapy for current cancer diagnosis. * Previous radiation therapy or concomitant radiotherapy for current cancer diagnosis. * Surgery within the last 4 weeks.

Design outcomes

Primary

MeasureTime frame
Feasibility of planned oncologic treatment (number of participants, who complete the planned oncologic treatment)2 years

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026